🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective was: \- to assess the bioequivalence of a single dos...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-09
Trial ID
NCT02237508
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The purpose of this study is to compare the test product Budesonide/formote...
Status
Completed
Location
Orion Pharma Phase I Unit
Start Date
2011-07
Trial ID
NCT01386996
Treatments Being Tested
A retrospective real-world data study, assessing the relationship between t...
Status
Completed
Location
AstraZeneca
Start Date
2024-08-15
Trial ID
NCT07103642
Treatments Being Tested
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
A phase III study, multicenter, randomized, parallel, open, two-period, com...
Status
Completed
Location
Eurofarma Laboratorios S.A
Start Date
2023-04-19
Trial ID
NCT04233190
Treatments Being Tested
The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the curr...
Status
Completed
Location
Helsinki University Hospital
Start Date
2021-11-11
Trial ID
NCT05084222
This study will evaluate whether prompt initiation and maintenance of Brezt...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-19
Trial ID
NCT05970263
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
The purpose of this study is to compare the early onset of effect of Symbic...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00646620
Treatments Being Tested